Abstract:Type 3C Diabetes, or diseases of the exocrine pancreas has been reported to occur in approximately 30% of adult patient with pancreatitis. The incidence of glucose abnormalities or risk factors that may predict the development of abnormal glucose in the pediatric pancreatitis population is not known. We performed a retrospective chart review from 1998-2016 for patients who carry the diagnosis of acute pancreatitis (AP), acute recurrent pancreatitis (ARP), and chronic pancreatitis (CP). We extracted glucose values, HbA1c%, and data from oral glucose tolerance and mixed meal testing with timing in relation to pancreatic exacerbations. Patient characteristic data such as age, gender, body proportions, family history of pancreatitis, exocrine function and genetic mutations were also assessed. Abnormal glucose was based on definitions put forth by the American Diabetes Society for pre-diabetes and diabetes. Fifty-two patients had AP and met criteria. Of those, 15 (29%) had glucose testing on or after the first attack, 21 (40%) were tested on or after the second attack (in ARP patients) and 16 (31%) were tested after a diagnosis of CP. Of the patients tested for glucose abnormalities, 25% (13/52) had abnormal glucose testing (testing indicating pre-DM or DM as defined by ADA guidelines. A significantly higher proportion of the abnormal glucose testing was seen in patients (85%, 11/13) with a BMI at or greater than the 85th percentile compared to the normal glucose patients (28%, 11/39) (p = 0.0007). A significantly higher proportion of the abnormal glucose patients (77%, 10/13) had SAP during the prior AP episode to testing compared to the 10% (4/39) of the normal glucose patients (p<0.0001). Older age at DM testing was associated with a higher prevalence of abnormal glucose testing (p = 0.04). In our patient population, a higher proportion of glucose abnormalities were after the second episode of pancreatitis, however 62% (8/13) with abnormalities was their first time tested. We identified obesity and having severe acute pancreatitis (SAP) during the prior AP episode to testing could be associated with abnormal glucose. We propose that systematic screening for abnormal glucose after the first episode of acute pancreatitis in order to better establish the timing of diabetes progression.

[Abnormal Metabolism of Glucose As Clue for Early Diagnosing Pancreatic Cancer].

Research on the Relationships Between Pancreatic Cancer and Hyperglycemia in Chinese Populations

Study on chemotherapy-induced glycated hemoglobin and fasting plasma glucose disorders of malignant tumor patients

A Retrospective Study on Metabolic Diseases As a Risk Factor for Pancreatic Cancer PING Jing-na, YAO

[Study on the Relationship Between Level of Glucose Metabolism and Risk of Cancer Incidents].

The Study of the Relationship Between Diabetes Mellitus and Pancreatic Cancer

Pancreatic Cancer-Associated Diabetes Mellitus is Characterized by Reduced Β-Cell Secretory Capacity, Rather Than Insulin Resistance

Biological and Clinical Impacts of Glucose Metabolism in Pancreatic Ductal Adenocarcinoma

Pancreatic Cancer: an Exocrine Tumor with Endocrine Characteristics.

Systemic Proteome Alterations Linked to Early Stage Pancreatic Cancer in Diabetic Patients

Clinical Clues of Pre-Symptomatic Pancreatic Ductal Adenocarcinoma Prior to Its Diagnosis: A Retrospective Review of CT Scans and Laboratory Tests

Metabolomics Identifies Biomarker Signatures to Differentiate Pancreatic Cancer from Type 2 Diabetes Mellitus in Early Diagnosis

Prevalence of abnormal glucose metabolism in pediatric acute, acute recurrent and chronic pancreatitis

New insights into pancreatic cancer-induced paraneoplastic diabetes

Hyperglycemia is Associated with Adverse Prognosis in Patients with Pancreatic Neuroendocrine Neoplasms

Early manifestations of pancreatic cancer: the effect of cancer-nerve interaction.

A Potential Screening Strategy of Pancreatic Cancer in New Onset Diabetes Patients Using Serum CA19-9 in Combination with Age and BMI

Relationship Between Neural Alteration and Perineural Invasion in Pancreatic Cancer Patients with Hyperglycemia

Serum Metabolomic Analysis Discriminates Pancreatic Cancer from New-Onset Diabetic Mellitus

Predictive Factors for Differentiating Pancreatic Cancer-Associated Diabetes Mellitus from Common Type 2 Diabetes Mellitus for the Early Detection of Pancreatic Cancer